Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate

This publication has 20 references indexed in Scilit:

• Synthesis and characterization of Respiratory Syncytial Virus protein G related peptides containing two disulfide bridges
  Chemical Biology & Drug Design, 2000
• Protective Efficacy against Respiratory Syncytial Virus following Murine Neonatal Immunization with BBG2Na Vaccine: Influence of Adjuvants and Maternal Antibodies
  The Journal of Infectious Diseases, 1999
• Respiratory Syncytial Virus Pneumonia among the Elderly: An Assessment of Disease Burden
  The Journal of Infectious Diseases, 1999
• Induction of Protective Immunity in Rodents by Vaccination with a Prokaryotically Expressed Recombinant Fusion Protein Containing a Respiratory Syncytial Virus G Protein Fragment
  Virology, 1997
• Hydrophobicity Engineering to Increase Solubility and Stability of a Recombinant Protein from Respiratory Syncytial Virus
  European Journal of Biochemistry, 1995
• An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines
  Virus Research, 1994
• Origin of Murine B Cell Lineages
  Annual Review of Immunology, 1993
• A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA
  Journal of Immunological Methods, 1989
• Production of Immunoglobulin Isotypes by Ly-1 ⁺ B Cells in Viable Motheaten and Normal Mice
  Science, 1986
• Progenitors for Ly-1 B cells are distinct from progenitors for other B cells.
  The Journal of Experimental Medicine, 1985